Effects of auro-detoxin treatment on vascular responses in mouse aorta. 1997

H Z Güney, and C Z Görgün, and U Hodoğlugil, and H Zengil
Department of Pharmacology, Faculty of Medicine, Gazi University, Ankara, Turkey.

1. In this study, we investigated the effects of chronic Auro-detoxin treatment for 5 and 10 weeks on reactivity to vascular agonists in the mouse aorta. 2. The maximum contractile responses to and the -log EC50 values of phenylephrine (Phe) were not changed with Auro-detoxin treatment. 3. The maximum contractile responses to 5-hydroxytryptamine (5-HT) were not changed over 5 weeks but were significantly increased with Auro-detoxin treatment during a 10-week period. The -log EC50 values of 5-HT were found to be significantly decreased in both treatment groups. 4. The maximum relaxation responses to acetylcholine (ACh) were decreased in both treatment groups. The -log EC50 values of ACh were not changed in 5 weeks but significantly decreased in 10 week-treated animals. 5. Neither the maximum relaxation responses not the -log EC50 values of sodium nitroprusside (SNP) were changed with Auro-detoxin treatment. 6. These results suggest that chronic gold treatment affects vascular responses in the mouse aorta.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009126 Muscle Relaxation That phase of a muscle twitch during which a muscle returns to a resting position. Muscle Relaxations,Relaxation, Muscle,Relaxations, Muscle
D009599 Nitroprusside A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins. Nitroferricyanide,Sodium Nitroprusside,Cyanonitrosylferrate,Ketostix,Naniprus,Nipride,Nipruton,Nitriate,Nitropress,Nitroprussiat Fides,Nitroprusside, Disodium Salt,Nitroprusside, Disodium Salt, Dihydrate,Disodium Salt Nitroprusside,Nitroprusside, Sodium
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005260 Female Females
D000109 Acetylcholine A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. 2-(Acetyloxy)-N,N,N-trimethylethanaminium,Acetilcolina Cusi,Acetylcholine Bromide,Acetylcholine Chloride,Acetylcholine Fluoride,Acetylcholine Hydroxide,Acetylcholine Iodide,Acetylcholine L-Tartrate,Acetylcholine Perchlorate,Acetylcholine Picrate,Acetylcholine Picrate (1:1),Acetylcholine Sulfate (1:1),Bromoacetylcholine,Chloroacetylcholine,Miochol,Acetylcholine L Tartrate,Bromide, Acetylcholine,Cusi, Acetilcolina,Fluoride, Acetylcholine,Hydroxide, Acetylcholine,Iodide, Acetylcholine,L-Tartrate, Acetylcholine,Perchlorate, Acetylcholine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001011 Aorta The main trunk of the systemic arteries. Aortas
D014662 Vasoconstrictor Agents Drugs used to cause constriction of the blood vessels. Vasoactive Agonist,Vasoactive Agonists,Vasoconstrictor,Vasoconstrictor Agent,Vasoconstrictor Drug,Vasopressor Agent,Vasopressor Agents,Vasoconstrictor Drugs,Vasoconstrictors,Agent, Vasoconstrictor,Agent, Vasopressor,Agents, Vasoconstrictor,Agents, Vasopressor,Agonist, Vasoactive,Agonists, Vasoactive,Drug, Vasoconstrictor,Drugs, Vasoconstrictor

Related Publications

H Z Güney, and C Z Görgün, and U Hodoğlugil, and H Zengil
January 1978, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
H Z Güney, and C Z Görgün, and U Hodoğlugil, and H Zengil
January 1977, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
H Z Güney, and C Z Görgün, and U Hodoğlugil, and H Zengil
November 1995, Experientia,
H Z Güney, and C Z Görgün, and U Hodoğlugil, and H Zengil
April 2000, Pharmacology,
H Z Güney, and C Z Görgün, and U Hodoğlugil, and H Zengil
February 2004, The Journal of pharmacy and pharmacology,
H Z Güney, and C Z Görgün, and U Hodoğlugil, and H Zengil
January 2002, American journal of physiology. Heart and circulatory physiology,
H Z Güney, and C Z Görgün, and U Hodoğlugil, and H Zengil
March 1946, Revista paulista de medicina,
H Z Güney, and C Z Görgün, and U Hodoğlugil, and H Zengil
April 1996, General pharmacology,
H Z Güney, and C Z Görgün, and U Hodoğlugil, and H Zengil
January 1990, Alcohol (Fayetteville, N.Y.),
H Z Güney, and C Z Görgün, and U Hodoğlugil, and H Zengil
July 1995, Yonsei medical journal,
Copied contents to your clipboard!